Ogier Bouvier

DOPPL SA is a spin out of SUN bioscience SA and a leader in engineering industry-standard organoids for disease modeling and personalized medicine. We engage in partnered projects for preclinical drug development by providing relevant, high-quality, and scalable organoid models.